Better Choice Company to Host Fourth Quarter and Full Year 2020 Earnings Call on March 31st at 8:30 a.m. ET
NEW YORK, March 22, 2021 (GLOBE NEWSWIRE) -- Better Choice Company (OTCQX: BTTR) (“Better Choice”), an animal health and wellness...
Staff
Catalyst Pharmaceuticals Announces $40 Million Share Repurchase Program
CORAL GABLES, Fla., March 22, 2021 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq:CPRX), a commercial-stage biopharmaceutical company focused on...
Tauriga Sciences Inc. Files International Patent Application, Relating to its Proposed Pharmaceutical Cannabinoid Chewing Gum, Under the Patent Cooperation Treaty
03_22 pr image In Blue – Countries that Adhere to PCT NEW YORK, NY, March 22, 2021 (GLOBE NEWSWIRE) --...
Reneo Pharmaceuticals Appoints Vineet R. Jindal as Chief Financial Officer
SAN DIEGO, March 22, 2021 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc., a clinical stage pharmaceutical company focused on the development...
Enlivex Announces Research Collaboration with Yale Cancer Center to Assess Synergistic Effect of Allocetra™ in Combination with Immune Checkpoint Inhibitors
Collaboration aims to evaluate the potential of Allocetra™ in combination with immune-checkpoint inhibitors in solid cancers that do not respond...
Applied Molecular Transport Appoints Earl Douglas as General Counsel
Company continues to strengthen key functions of corporate leadership Company on track to announce oral AMT-101 top-line data readouts from...
Amolyt Pharma Presents First Clinical Data for AZP-3601, its Parathyroid Hormone Analog for Hypoparathyroidism, at the Endocrine Society’s Virtual Annual Meeting (ENDO 2021)
Data from first 4 cohorts of the single ascending dose (SAD) study show that AZP-3601 induced a long-acting serum calcium...
AVITA Medical, Inc. Names Michael Holder as Chief Financial Officer
VALENCIA, Calif. and MELBOURNE, Australia, March 22, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (Nasdaq: RCEL; ASX: AVH) (“AVITA Medical”),...
Terranueva Closes a Private Placement of $1,050,000
L’ASSOMPTION, Québec, March 22, 2021 (GLOBE NEWSWIRE) -- TERRANUEVA CORPORATION (CSE : TEQ) (“Terranueva” or the “Corporation”) is pleased to announce the...
Rezolute Presents Data on RZ358 in Post-Gastric Bypass Hypoglycemia at ENDO 2021
REDWOOD CITY, Calif., March 22, 2021 (GLOBE NEWSWIRE) -- Rezolute, Inc. (“Rezolute” or “the Company”) (Nasdaq: RZLT) today presented positive...
The Augustinians Fathers and Mariann Home announce expansion and relocation of long-term care facility to the Marylake Campus in King Township
KING TOWNSHIP, Ontario, March 22, 2021 (GLOBE NEWSWIRE) -- The Marylake Augustinian Fathers in King City and the Midwest Augustinian...
Decibel Therapeutics Added to Russell 2000 Index
BOSTON, March 22, 2021 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX) (“Decibel”), a clinical-stage biotechnology company dedicated to discovering and...
Sensei Biotherapeutics Announces Inclusion in Russell 2000 Index
BOSTON and ROCKVILLE, Md., March 22, 2021 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical-stage immunotherapy company focused...
BioCryst’s Oral Factor D Inhibitor, BCX9930, Advancing to Pivotal Trials in PNH Following Successful Proof of Concept Trial
—Following doses of 400 mg bid or 500 mg bid of oral BCX9930, 100 percent of treatment-naïve patients and 83...
Context Therapeutics® Expands Board of Directors
-- Company Adds Richard Berman, Jennifer Evans Stacey and Linda West to Board -- -- Appointments Bolster Business and Clinical...
Shockwave Announces Joint Venture in China
Establishes a Company to Maximize the Availability of IVL for the Chinese PopulationSANTA CLARA, Calif., March 22, 2021 (GLOBE NEWSWIRE)...
RAPT Therapeutics Completes Enrollment in Phase 1b Trial of RPT193 in Atopic Dermatitis
Company Reaffirms Guidance to Report Data in 1H 2021SOUTH SAN FRANCISCO, Calif., March 22, 2021 (GLOBE NEWSWIRE) -- RAPT Therapeutics,...
Daré Bioscience Completes Recruitment in Phase 1 Clinical Trial of DARE-HRT1, a Novel Intravaginal Ring Designed to Deliver Non-Oral, Bio-identical Hormone Therapy for the Treatment of Vasomotor Symptoms and Genitourinary Syndrome Associated with Menopause
Topline data readout anticipated in the second quarter 2021SAN DIEGO, March 22, 2021 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a leader...
Humana Expands Use of the Inovalon ONE® Platform
Leading National Health Plan to Implement Vaccine Adherence ProgramBOWIE, Md., March 22, 2021 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV), a leading provider...
Terns Announces Initiation of Dosing in Phase 1 Clinical Trial of TERN-501, its THR-Beta Agonist in Development for the Treatment of NASH
-TERN-501 is designed to have high metabolic stability, enhanced liver distribution and high selectivity for THR-β- -Top-line data expected in...